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Context: The bile acids receptors Farsenoid X and TGR5 protect against
the formation of atheroma in mice, though no evidence have linked coronary
atheroma and bile acid in human. Bile acids links these receptors with more
or less efficient activation, depending on the species.
Objective: To test the hypothesis that changes in concentrations of circu-
lating bile acid species influence the risk of developing coronary atheromas in
humans.
Methods: Pilot, prospective, observational study conducted between June
and September 2010. The serum concentrations of cholic, chenodeoxycholic,
deoxycholic, and lithocholic acids were measured in a fasting blood sample.
Consecutive hospitalized or ambulatory patients undergoing emergency or
elective coronary angiograms were eligible for inclusion. Post-cardiac arrest
and non-fasting states, hepatic disease, and treatment with antimicrobials, cor-
ticosteroids, statins or fibrates were exclusion criteria. Of 393 screened
patients, 44 met the study entry criteria, and were divided between 27 patients
with (Group A) and 17 without (Group B) angiographically visible coronary
atheromas. The pool of circulating bile acids was analyzed to measure the
plasmatic concentrations of 28 different bile acid species. The variables asso-
ciated with the presence of angiographically visible coronary atheromas were
examined by single and multiple variable logistic regression analysis.
Results: The serum lithocholic acid concentration was significantly lower
in group A than in group B. By multiple variable analysis, lithocholic acid was
the only predictor of coronary atheroma independently of patient gender (odds
ratio 2.41 per 0.05 decrease; 95% confidence interval 1.11 to 5.25, P=0.027
Conclusion: A low serum concentration of lithocholic acid was an inde-
pendent predictor of coronary atheroma in human.
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Cardiovascular alterations in the septic shock include an hypotension asso-
ciated with a cardiomyopathy. The sympathetic regulation of the cardio-
vascular system is impaired during the shock and associated with an altered
endothelial function. However, involved cellular mechanisms are not clear.
The aims of this project were to determine the role of the three β-adrenoceptor
subtypes, β1, β2 and β3-AR in the cardiac dysfunction in endotoxemic rats.
Methods: Rats (12w) received either endotoxin (LPS, 5mg. kg-1) or saline
i.v. (C). 3h later, cardiac parameters were studied in vivo by echocardiography.
Selective β-AR responses were studied on papillary muscle contractility with
or without a functional endothelium. Endothelium damage was realized with
3s Triton X-100 at 0.5%.
Results: In vivo, LPS rats presented altered systolic (shortening frac-
tion –21±4% vs C p<0.05) and diastolic (E wave –47±4% vs C p<0.05) func-
tions. In papillary muscle, isoproterenol (non selectif βAR agonist) induced
contractility was increased in LPS (+105±21% vs C; p<0.05). This increase
did not result from β3-AR and β2-AR because there expressions were respec-
tively decreased by 20±4%; (p<0.05 vs C) and 47±7% (p<0.05 vs C) in LPS
and correlated to a maintained β3-AR-induced contractility and a decreased β2-
AR (–38±8% vs C; p<0.05). The β2-AR-induced contractility was not modi-
fied in LPS muscle without endothelium whereas it was reduced in C muscle
without endothelium (79±6% vs C; p<0.05). Conversely, albeit β1-AR expres-
sion was decreased (–66±5% vs C; p<0.05), β1-AR response was increased in
papillary muscles (+94±16% vs C; p<0.05) from LPS rats. Surprisingly, the
disrupted endothelium abolished this increase.
Conclusion: Our results demonstrate, for the first time, an increased β1-AR
contractility, on papillary muscle form LPS rats, dependent of the functional
endothelium. This suggests that β1-AR could be involved in the persistent tachy-
cardia observed in the shock leading to propose β1-AR blockers in this disease.
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Baseline
=186 (%)
Year 1
=153 
(%)
Year 2
=141 (%)
Year 3
=137 
(%)
Year 4
=128 
(%)
SCORE 25 (13.4) 20 (13.1) 23 (16.3) 25 (18.2) 28 (21.9)
SCORE × 1,5
(2 conditions)
26 (14) 20 (13.1) 23 (16.3) 25 (18.2) 28 (21.9)
SCORE × 1,5
(1 condition)
49 (26.3) 54 (35.3) 49 (34.7) 60 (43.8) 59 (46.1)
CEP (FRS) 51 (27.4) 41 (26.8) 30 (21.3) 32 (23.4) 44 (34.4)
CEP × 1,5
(2 conditions)
51 (27.4) 42 (27.4) 30 (21.3) 32 (23.4) 44 (34.4)
CEP × 1,5
(1 condition)
54 (29) 44 (28.7) 31 (22) 32 (23.4) 45 (35.2)
AFSSAPS
(FRS global)
21 (11.3) 14 (9.2) 11 (7.8) 14 (10.2) 22 (17.2)
AFSSAPS
(FRS global) × 
1,5
(2 conditions)
22 (11.8) 15 (9.8) 11 (7.8) 14 (10.2) 22 (17.2)
AFSSAPS
(FRS global) × 
1,5
(1 condition)
33 (17.7) 27 (17.6) 22 (15.6) 23 (16.8) 30 (23.4)
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